SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

The DOE’s plan for AI in NRC licensing

April 2, 2026, 9:40AMNuclear News

The Department of Energy announced the completion of a proof-of-concept demonstration of the use of Everstar’s AI tool to generate chapter 5 of an NRC license application from preliminary...